Review of red yeast rice content and current Food and Drug Administration oversight

Journal of Clinical Lipidology

Volumn 7, Issue 2, 2013, Pages 117-122

  Childress, Lindsey ^a   Gay, Andrea ^a   Zargar, Atanaz ^a   Ito, Matthew K ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Dietary supplements; Food and Drug Administration; Hyperlipidemia; Red yeast rice; Statins

Indexed keywords

CHOLESTIN;

ARTICLE; DATA BASE; DRUG INDUSTRY; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL;

BIOLOGICAL AGENTS; CITRININ; DIETARY SUPPLEMENTS; GOVERNMENT REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LOVASTATIN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84874118407     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.09.003     Document Type: Article

References (24)

1. D.J. Becker, J. Gordon, S.C. Halbert, B. French, P.B. Morris, and D.J. Rader Red yeast rice versus placebo in dyslipidemic, statin-intolerant patients enrolled in a therapeutic lifestyle program: a randomized, controlled trial Ann Intern Med 150 2009 830 839
2. S.C. Halbert, B. French, and R.Y. Gordon Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance Am J Cardiol 105 2010 198 204
3. The 2009 Supplement Business Report. Boulder, CO: Nutrition Business Journal; 2009:44.
4. M.P. Bogsrud, L. Ose, and G. Langlet HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study Scand Cardiovasc J 44 2010 197 200
5. A. Endo, and M. Kurodoa Citrinin, an inhibitor of cholesterol synthesis J Antibiot (Tokyo) 29 1976 841 843
6. M. Sabater-vilar, R.F.M. Maas, and J. Fink-Gremmels Mutagenicity of commercial Monascus fermentation products and the role of citrinin contamination Mutation Red 444 1999 7 16 (Pubitemid 29341520)
7. J. Liu, K. Zhang, Y. Shi, S. Grimsgaard, T. Alraek, and V. Fonnebo Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials Chin Med I4 2006
8. Z. Lu, W. Kou, and B. Du Effects of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction Am J Cardiol 101 2008 1689 1693
9. Dietary Supplement Health and Education Act of 1994, Public Laq 103-417, 103rd Congress. General Dietary Supplement Labeling. Chapter I. Available at: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ GuidanceDocuments/DietarySupplements/DietarySupplementlabelingguide/ucm070519. htm#1-1. Accessed March 3, 2012.
10. US Food and Drug Administration. FDA issues dietary supplements final rule. FDA News. Guidance for Industry: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Small Entity Compliance Guide. Available at: http://www.fda.gov/ Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/ SmallBusinessesSmallEntityComplianceGuides/ucm238182.htm. Accessed March 3, 2010.
11. T.A. Pearson Commentary: lipid-lowering therapy in low risk patients JAMA 179 1998 1659 1661 (Pubitemid 28248594)
12. R.Y. Gordon, T. Cooperman, W. Obermeyer, and D.J. Becker Marked variability of monacolin levels in commercial red yeast rice products: buyer beware Arch Intern Med 170 2010 1722 1727
13. D. Heber, A. Lembertas, Q.Y. Lu, S. Bowerman, and V.L. Go An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents J Altern Complement Med 7 2001 133 139 (Pubitemid 32319321)
14. J.J. Woo Adverse event monitoring and multivitamin-multimineral dietary supplement Am J Clin Nutr 85 2007 323S 324S (Pubitemid 46067657)
15. B.B. Timbo, M.P. Ross, P.V. McCarthy, and C.T. Lin Dietary supplements in a national survey: prevalence of use and reports of adverse events J Am Diet Assoc 106 2006 1966 1974 (Pubitemid 44779443)
16. Natural Medicines Comprehensive Database [Internet Database]. Stockton, CA: Therapeutic Research Faculty. Updated periodically.
17. P. Hsu Natural Medicines Comprehensive Database J Med Libr Assoc 90 2002 114
18. United Stated Pharmacopeia Verified Dietary Supplements. Rockville, MD: United States Pharmacopeia; Updated periodically.
19. ConsumerLab.com. White Plains, NY: ConsumerLab.com, LLC; Updated periodically.
20. National Sanitation Foundation. Ann Arbor, MI: NSF International; Updated periodically.
21. Natural Products Association. Washington, DC: Natural Products Association; Updated periodically.
22. Product information Mevacor (lovastatin) May 2010 Merck & Co., Inc. Whitehouse Station, NJ
23. J.D. Cohen, E.A. Brinton, M.K. Ito, and T.A. Jacobson Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users J Clin Lipidol 6 2012 208 215
24. A. Bakhai, U. Rigney, S. Hollis, and C. Emmas Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population Pharmacoepidemiol Drug Saf 21 2012 485 493